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The present study was undertaken to evaluate the possible reno-protective effect
of Ficus exasperata leaf aqueous extract (FEE) in a rat experimental paradigm of
diabetes mellitus. Forty Wistar rats (weighing 200–230 g) were divided into four
(A, B, C, and D) groups, each group consisting of 10 rats. Group A rats served as
‘control’ animals and received citrate buffer (pH 6.3) solution in quantities equiva-
lent to intraperitoneally-administered volumes of streptozotocin (STZ) and FEE.
Diabetes mellitus was induced in Groups B and C rats by intraperitoneal injections
of STZ (75 mg/kg). Group C rats were additionally treated with FEE (100 mg/kg/
/day, p.o.) 4 weeks post STZ injections, for 4 consecutive weeks. Group D rats
received FEE (100 mg/kg/day p.o.) only for 4 weeks. Post-euthanisation, kidney
tissues were excised for histopathological evaluation and processed for light mi-
croscopy. Plasma malondialdehyde and tissue nitric oxide were determined. Se-
rum creatinine, blood urea nitrogen, nitrite, and albumin concentrations were
measured for the evaluation of renal function. The diabetic rats significantly lost
more weight and their blood glucose levels were significantly elevated as com-
pared to the ‘control’ group of animals. Renal dysfunction was evidenced by kid-
ney hypertrophy, decreased renal blood flow, and increased serum creatinine and
nitrite concentrations. Furthermore, vascular dysfunction, as evidenced by decreased
carotid blood flow, was observed in the diabetic rats. FEE treatment positively
ameliorated the alterations in the biochemical variables in the STZ + FEE-treated
rats. In conclusion, our findings suggest that FEE treatment ameliorates STZ-in-
duced nephrotoxicity. (Folia Morphol 2012; 71, 1: 1–9)
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INTRODUCTION
Diabetes mellitus (DM) is a major global health
problem, which is now becoming an epidemic. The
latest WHO publication (global burden of disease)
estimates DM in adults to be around 200 million,
and about two thirds of diabetics live in developing
countries. It is a metabolic disease characterised by
high blood glucose levels, resulting from defects in
insulin secretion, insulin action, or both [14]. The
prevalence of DM is increasing and it is expected to
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increase further by approximately 5.4% by 2025. An
increase in sedentary lifestyle, consumption of an
energy-rich diet, and obesity are some of the factors
accountable for the rise in the number of diabetics.
However, Asia and Africa are identified as regions with
the greatest potential, where the number of diabe-
tics could rise to two- or three-fold above the present
level. In traditional African societies, phytotherapy is
highly valued and widely utilised for various human
ailments, including DM. Indeed, the majority of the
African populations use plant materials as their only
source of primary healthcare [5].
Diabetes is the most common cause of kidney
failure, accounting for nearly 44% of new cases of
kidney disorders [23]. Even when diabetes is con-
trolled, the disease can lead to chronic kidney dis-
ease (CKD) and kidney failure. However, most peo-
ple with diabetes do not develop CKD that is severe
enough to progress to kidney failure. As the disease
progresses, more albumin leaks into the urine, a situ-
ation known as “macroalbuminuria” or “proteinu-
ria”. As the amount of albumin in the urine increas-
es, the kidney’s filtering function usually begins to
drop. The body then starts to retain various waste
products as filtration falls. As kidney damage deve-
lops, blood pressure often rises as well.
Streptozotocin (STZ) is a broad-spectrum antibio-
tic with oncogenic and diabetogenic properties. The
diabetogenic action is mediated by selective destruc-
tion of pancreatic beta cells, which are known as insu-
lin producing cells. Consequently, STZ has been wide-
ly utilised as a method for inducing DM in experimen-
tal animals, and for the treatment of malignant beta
cell tumours and other neoplasms in humans [22]. To
produce diabetes, STZ is conventionally administered
as a single injection. STZ is cleared from the blood
stream rapidly (with serum half-life of 15 min). Beta
cell necrosis can be detected by electron microscopy
within hours after STZ injection. Elevated blood glu-
cose levels are demonstrable within 1–2 days, while
dissolution and phagocytosis of necrotic cells are ob-
servable histologically after three days [3].
Ficus exasperata (Vahl) is known locally as “sand
paper tree”. It grows wild uncultivated in the rainfor-
est belt of tropical Africa. It is a medicinal plant used
for treating different human diseases. The water in
which the stem-bark is boiled is usually given to cows
to hasten afterbirth [7]. The sap is used to arrest bleed-
ing in Ghana [1]. The viscid, non-milky sap is used for
treating sores, eye trouble, and stomach pains in Ivo-
ry Coast [2]. The sap is also used by traditional birth
attendants in Congo to ease childbirth. In South Af-
rica, scrapings of the bark are used in an embroca-
tion for body pains, and also as a stimulant [2]. In
Zaire, a leaf poultice is used in a medication for ring-
worm [2]. Nimenibo-Uadia [12] reported that admin-
istration of aqueous extracts of F. exasperata result-
ed in decreased plasma triacylglycerol and b-OH-bu-
tyrate levels in alloxan-treated diabetic rats.
Several in vivo and in vitro studies have demon-
strated marked down-regulation of nitric oxide (NO)
production, and NO synthase (NOS) abundance in
diabetic animals as well as in cultured endothelial
and mesangial cells subjected to simulated hyperg-
lycaemia [4]. The present study was designed to:
(i) investigate the hypoglycaemic effect of F. exaspe-
rate leaf aqueous extract (FEE), (ii) explore the extract’s
possible role in NO production as well as in renal NOS
expression, and (iii) examine the plausible reno-pro-
tective effect of FEE in STZ-treated Wistar rats.
MATERIAL AND METHODS
Animal care and monitoring
This study was carried out in healthy, male and
female, young adult, Wistar rats (Rattus norvegicus)
weighing 250–300 g. The animals were housed un-
der standard laboratory conditions of light, temper-
ature (21 ± 1oC), and relative humidity (55 ± 5%)
and were fed with standard rat pellets and drinking
tap water ad libitum. The rats were randomly divid-
ed into four (A, B, C, and D) experimental groups.
The maintenance and treatment of the animals were
in accordance with the principles of the “Guide for
the care and use of laboratory animals in research
and teaching” prepared by the National Institute of
Health (NIH) [publication 86–23, revised in 1985].
Experimental design
The animals were divided into four groups of 10 rats
each. Group A rats were treated with citrate buffer
(pH 6.3) solution in quantities equivalent to the admi-
nistered volumes of STZ and FEE intraperitoneally. The
rats in groups B and C were treated with STZ (intraperi-
toneal injections of STZ, 75 mg/kg). Group C rats were
additionally treated with FEE (100 mg/kg/day, p.o.)
4 weeks post STZ injection, for 4 consecutive weeks.
Group D rats received FEE (100 mg/kg/day p.o.) only for
4 weeks. The mice were used for acute toxicity testing of
the plant’s crude extract, while the rats were used for
hypoglycaemic and histopathological evaluations of the
plant’s extract. All the animals were fasted for 16 hours,
but still allowed free access to drinking tap water, be-
fore the commencement of our experiments. At the end
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of our experimental period of 8 weeks, the animals were
sacrificed by cervical dislocation; serum/plasma samples
and kidney tissue were collected and stored at –80oC
for analysis.
Plant material
Fresh leaves of F. exasperata Vahl [family: Mora-
ceae] (locally known as “sand paper tree” or “Ipin” in
Yoruba language of Western Nigeria) were collected
from suburban villages of the Ile-Ife metropolis in
Osun State of Nigeria, between March and April 2009.
The leaves were botanically identified by the taxono-
mist and curator of the Department of Botany,
Obafemi Awolowo University, Ile-Ife, Nigeria. A vouch-
er specimen of the plant has been deposited in the
University’s Botany Departmental Herbarium.
Preparation of F. exasperata leaf aqueous extract
Fresh leaves of F. exasperata were air-dried at
room temperature. One kilogram (1 kg) of the air-
dried leaves of the plant was milled into a fine pow-
der in a Warring commercial blender. The powdered
leaves were macerated in distilled water and extract-
ed twice, on each occasion with 2.5 L of distilled water
at room temperature for 48 h. The combined filtered
aqueous extract solubles were concentrated to dry-
ness under reduced pressure at 60 ± 1oC in a rotary
evaporator. The resulting aqueous extract was freeze-
dried; finally giving 46.18 g (i.e. 4.618% yield) of
a dark-green, powdery, crude leaf aqueous extract of
F. exasperata (FEE). Aliquot portions of the crude ex-
tract residue were weighed and dissolved in distilled
water for use on each day of our experiment.
Induction of experimental diabetes
Diabetes mellitus was induced in Groups B and
C ‘test’ rats by intraperitoneal (i.p.) injections of STZ
(75 mg/kg/body weight), freshly dissolved in 0.1 mol/L
citrate buffer [17]. Group A ‘control’ rats received i.p.
volumes of citrate buffer solution (pH 6.3) equiva-
lent to the volumes of STZ administered. The ‘test’
animals in groups B and C became diabetic within
48 h after STZ administration. Diabetes was allowed
to develop and stabilise in these STZ-treated rats over
a period of 3–5 days. Group C rats additionally re-
ceived oral administrations of FEE (100 mg/kg/day)
daily from the 4th week post STZ treatment. All the
animals in groups A, B, C, and D were kept and main-
tained under laboratory conditions of light, humidi-
ty, and temperature. Before the commencement of
our experiments, both the normal (normoglycaemic)
‘control’ and STZ-treated diabetic (hyperglycaemic)
‘test’ rats were fasted for 16 h but still allowed free
access to drinking tap water throughout. At the end
of the 16-h fasting period — taken as 0 time (i.e. 0 h)
— blood glucose levels (initial glycaemia, G0) of the
fasted normal and STZ-treated diabetic rats were
determined and recorded.
Blood glucose determination
Blood samples (0.02 mL) were obtained from each
rat by repeated needle puncture of the tail tip vein.
Blood samples were taken 1 day before STZ- and FEE-
-treatments and also on various days after the induc-
tion of DM and the commencement of our experiment.
Blood glucose concentrations were determined by
means of Bayer’s Elite® Glucometer and compatible
blood glucose test strips. Fasted STZ–treated rats with
blood glucose concentrations ≥ 18 mmol/L were con-
sidered to be diabetic and were used in this study.
The test compound (i.e. Ficus exasperata leaf aque-
ous extract [FEE, 100 mg/kg/day p.o.]) was adminis-
tered orally by intragastric intubation to fasted
Groups B and C rats. In both Groups B and C rats,
administration of FEE (100 mg/kg) commenced as
from the end of the 4th week post STZ injection, and
continued for the next 4 consecutive weeks.
Common carotid arterial blood flow measurement
Under pentobarbital (50 mg/kg i.p.) anaesthesia,
rats were placed in dorsal recumbency, and through
a midline cervical incision the left common carotid ar-
tery was identified and carefully separated from ad-
hering connective tissues. The carotid artery was
cleared from the vagal nerve and a Transonic© flow
probe (0.3 mm 1RB, Transonic Systems Inc., Itheca,
NY) was carefully placed around the artery. The probe
was manually positioned so that the artery was cen-
tred within its window, and the probe was held in
position. Through a sterile 10 cc syringe loaded with
sterile K-Y brand lubricating jelly (Johnson & Johnson,
Arlington, TX), the acoustical window within the flow
probe was filled while avoiding any air bubbles.
Renal arterial blood flow measurement
Under pentobarbital (50 mg/kg i.p.) anaesthe-
sia, rats were placed in dorsal recumbency, and
through a midline abdominal skin incision the left
renal artery was carefully separated from renal vein
and a 0.5 VB Transonic© flow probe was placed
around it. The probe was manually positioned so
that the artery was centred within the window and
the probe was held in position. The acoustical win-
dow within the flow probe was filled with sterile
4Folia Morphol., 2012, Vol. 71, No. 1
K-Y brand lubricating jelly (Johnson & Johnson, Ar-
lington, TX). Renal and carotid artery blood flows
were measured using Transonic© flow meter T206
attached to MP100 System of Biopac Systems Inc.,
CA, via analogue-to-digital conversion. The MP100
System was calibrated with the minimum and max-
imum flow capacity of the individual probe connect-
ed to the flow meter. Sampling of data was carried
out at 1000 Hz and recorded by a dedicated com-
puter using AcqKnowledgeTM software.
Determination of the concentration
of nitric oxide by-products (NOx)
The concentrations of endogenous NOx (nitrite +
+ nitrate) were determined in plasma and kidney cor-
tex and medulla. Blood (500 mL) was collected into
a heparinised specimen bottle. The blood sample was
decanted and stored at –20oC until ready for use.
Renal samples were harvested from each rat and
immediately homogenised with cold phosphate buf-
fered saline (PBS) on ice, which inhibited the activity of
nitric oxide synthase ex-vivo. The homogenate was cen-
trifuged (3000 ¥ g, 5 min) and the supernatant was
collected. The supernatant obtained from tissues and
plasma was passed through a 1.2 mm multiscreen filter
plate. Plasma and tissue nitrite/nitrate levels were de-
termined by converting the nitrate to nitrite, using en-
zyme nitrate reductase (Boehriger Mannheim) followed
by the addition of Griess Reagent to colourimetrically
quantify the nitrite concentration [18]. The plasma was
diluted 1:5 in PBS before a 25-mL aliquot was added to
a mixture of 25 mL nitrate reductase (1.5 U/mL) and
25 mL of NADPH (0.134 mg/mL), both prepared in 40 mM
Tris, pH 7.6. The samples were thereafter incubated at
room temperature for 3 h. Following this incubation
period, 100 mL of Griess Reagent (1:1 mixture of 1%
sulphanilamide in 5% phosphoric acid and 0.1% naph-
thyl-ethylenediamine) was added and incubated for
a further 10 min at room temperature.
The absorbency of the samples was measured at
540 nm with a 650 nm reference. The concentration
of nitrite/nitrate was determined from a standard
curve of sodium nitrate, and calculated as mmol/g
protein in tissues. Protein in the supernatant ob-
tained from samples was determined using stan-
dard Lowry method [11].
Thiobarbituric acid reactive substances
The product of the reaction between malondi-
aldehyde (MDA) and thiobarbituric acid reactive sub-
stances (TBARS) was measured by a modified me-
thod of Ohkawa et al. [13]. For each sample to be
assayed, four tubes were set up containing 100, 150,
200, and 250 mL of plasma, 100 mL of 8.1% SDS,
750 mL of 20% acetic acid, and 750 mL of 0.8% aque-
ous solution of TBA. The volume was made up to
4 mL with distilled water, mixed thoroughly, and
heated at 95oC for 60 min. After cooling, 4 mL of n-
butanol was added to each tube, the contents mixed
thoroughly, and then centrifuged at 3000 rpm for
10 min. The absorption of the clear, upper (n-bu-
tanol) layer was measured using a Shimadzu (Ja-
pan) UV-1601 spectrophotometer at 532 nm. The
concentration of MDA was calculated by the absor-
bance coefficient of MDA-TBA complex 1.56 ¥ 105/
/cm/M, and was expressed in  mmol TBARS/L.
Renal histopathology
Renal tissues were excised from sacrificed animals,
individually weighed, and thin kidney slices were cut,
fixed in 4% paraformaldehyde, and sequentially em-
bedded in paraffin wax blocks. Tissue sections of
5 mm thickness were cut and stained with haematox-
ylin-eosin (H-E) and Masson’s trichrome [20] for con-
ventional morphological evaluation, and subsequent-
ly examined under light microscope (BX50; Olympus,
Tokyo). Images were obtained by a digital camera
system (Pixcera Co., Osaka, Japan) attached to the
microscope. A minimum of 10 fields for each kidney
slide were examined and scored semi-quantitatively
for severity of changes by a pathologist unaware of
the type of treatment. The scoring was done as none
(–), mild (+), moderate (++), and severe (+++).
Determination of creatinine (Cr) and blood
urea nitrogen levels and clearances (Ccl)
Before sacrifice, the rats were kept individually in
metabolic cages (TP-85M; Toyoriko, Tokyo). After 4–5
days of adaptation, urine samples were collected in
ice-cooled glass flasks every 8 h for 24 h and stored at
4oC. Urine samples from each rat were combined and
measured. After centrifugation, aliquots of the super-
natant were frozen at –40oC. Rats were sacrificed (un-
der light anaesthesia with halothane) by decapitation.
The abdomen was opened by transverse incision, and
the kidneys were excised for histological studies and
enzymatic analysis. Blood samples were collected by
cardiac puncture into heparinised containers. Blood
urea nitrogen (BUN) values as indicators of renal dam-
age were determined by NADH-coupled enzymatic
method, using urease spectrophotometrically in an
enzyme-based assay [8]. Urine and serum samples were
assayed for creatinine using the spectrophotometric
assay method of Junge et al. [10]. For the assay, urine
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was diluted 1:50 in distilled water. Three microliters
of plasma or diluted urine and 300 mL picric acid re-
agent (consisting of saturated aqueous picric acid di-
luted 5-fold in 0.25 M NaOH) were dispensed in dupli-
cate, using a MicroLab dilutor (Hamilton, Reno, NV)
into wells of a microtiter plate. After incubation for
15 min at room temperature, absorbance was read at
515 nm in a microplate reader. Creatinine clearance was
calculated according to the Cockcroft-Gault formula
(Cockcroft and Gault, 1976). Ccr = (Cu/Cs) × V, where
Cu is the concentration of creatinine in urine, Cs is the
concentration of creatinine in serum, and V is the urine
flow rate in millilitres per minute.
Serum and urine albumin concentrations
Serum albumin concentration was measured in
a Multistat III Plus machine with reagents from Fisher
Scientific (St. Louis, MO). Urine samples were col-
lected in test tubes and stored at –40oC for analysis.
The concentration of urinary albumin was deter-
mined using standard diagnostic kits, an enzyme-
-linked immunosorbent assay (ELISA) (Nephrat Exo-
cell Inc., Philadelphia, PA, USA).
Assessment of urine/serum and
tissue nitrite concentration
Urine samples were deproteinised by equal vo-
lumes of 0.3 M NaOH and 5% zinc sulphate and cen-
trifuged at 6400 ¥ g for 20 min. The supernatants
were added in duplicates to 96-well plates and re-
acted with Greiss Reagent (1:1 solution of 1% sul-
phanilamide in 5% phosphoric acid and 0.1%
napthaylamine diamine dihydrochloric acid in water).
Also, serum and tissue nitrite were estimated using
Griess Reagent and served as an indicator of NO pro-
duction; 500 mL of Greiss Reagent was added to suit-
ably diluted 100 mL of serum and supernatant of the
tissue as described above and corrected by protein
amount. Nitrite levels were assessed by measurement
of absorbance at 540 nm using a microplate reader
(Model 550; Bio-Rad laboratories, Hercules, CA) [6].
Nitrite concentration was calculated using a standard
curve for sodium nitrite. Nitrite levels were expressed
as mmol/mL in serum and urine and as mmol/mg pro-
tein in homogenate, respectively.
Statistical analysis
Results are presented as means ± EM). Analysis
of variance (ANOVA) with post hoc multiple com-
parison test and Wilcoxon signed-rank test were
used in statistical analysis of the data. A p values
less than 0.05 were considered significant.
RESULTS
General characteristics of the animals
The untreated diabetic group of rats exhibited
a significant (p < 0.05) body weight loss during the
4-week study period. FEE treatment prevented diabe-
tes-induced weight loss and facilitated the growth of
animals, albeit at a moderately slower rate than seen
in the ‘control’ normal animals (Table 1). Administra-
tion of STZ also resulted in a significant (p < 0.05)
increase in kidney weight when compared with the
normal ‘control’ and FEE-treated groups of rats. The
FEE treated group of rats showed insignificant chang-
es in kidney and body weights (Table 1).
Urine/serum and tissue nitrite levels
STZ treatment significantly increased (p < 0.05)
urine, serum, and tissue nitrite levels in STZ-treated
rats. F. exasperata treatment significantly decreased
(p < 0.05) the elevated nitrite levels in urine, serum,
and tissues of STZ + FEE-treated rats. However, FEE
per se has no significant effect (p > 0.05) on urine,
serum, and tissue nitrite levels of group D rats (Fig. 1).
Serum creatinine, blood urea nitrogen,
and albumin levels
STZ treatment significantly increased (p < 0.05)
serum creatinine, BUN, and urine albumin levels as
compared with the ‘control’ group of rats. However,
serum albumin levels were significantly lower (p < 0.05)
in STZ-treated rats (Table 2). Although treatment
of the diabetic rats with FEE significantly prevented
a rise in serum creatinine, BUN, and urine albumin, the
Table 1. Body and kidney weights of ‘control’, STZ-, STZ + FEE-, and FEE-treated rats and urinary volume per day
Parameter Control STZ STZ + FEE FEE
Body weight [g] 240.1 ± 2.0 210.3 ± 0.4* 232.2 ± 2.6 242.4 ± 3.2
Kidney weight [g] 0.94 ± 0.32 1.47 ± 0.91* 1.03 ± 0.14 0.96 ± 0.12
Urine volume [mL/day] 20.1 ± 2.3 38.2 ± 1.4* 24.4 ± 0.3 20.7 ± 3.2
Values are expressed as means ± SEM of 8–10 rats for all groups; *significant difference (p < 0.05) in the same row between various treatments and ‘control’ group A rats
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extract at the same time increased serum albumin in
the STZ + FEE group of rats (Table 2). Creatinine and
urea clearance, which were markedly decreased in STZ-
-treated rats, were significantly increased by FEE treat-
ment (Table 2), but the extract did not restore creati-
nine and urea clearance values to the level seen in the
normal, ‘control’ animals. FEE treatment per se, how-
ever, had no significant effect (p > 0.05) on these bio-
chemical variables in group D rats (Table 2).
Renal and carotid blood flow
Induction of STZ diabetes produced a significant
increase (p < 0.05) in renal and carotid blood flow
throughout our experimental period (Fig. 2). Control
and FEE-treated (group D) rats exhibited normal renal
and carotid blood flow. A remarkable improvement
was seen in group C rats treated with FEE (Fig. 2).
Urine/serum and tissue nitrite levels
Administration of STZ significantly increased
(p < 0.05) urine, serum, and tissue nitrite levels in STZ-
-treated rats. F. exasperata leaf aqueous extract treat-
ment significantly decreased (p < 0.05) the elevat-
ed nitrite levels in urine, serum, and tissues of STZ +
+ FEE-treated rats. However, FEE per se had no sig-
nificant effect (p > 0.05) on urine, serum, and tis-
sue nitrite levels of group D rats (Table 2, Fig. 1).
Plasma and kidney malondialdehyde results
The untreated diabetic animals exhibited
a marked increase (p < 0.05) in both plasma MDA
levels and kidney MDA contents when compared
with ‘control’ and FEE-treated rats (Fig. 3). This ob-
servation probably suggests an increased ROS-me-
diated lipid peroxidation in the diabetic animals. FEE
Table 2. Assessment of renal functions in the experimental animal groups treated with STZ and FEE
Parameter Control STZ STZ + FEE FEE
Serum creatinine [mg/dL] 0.66 ± 1.0 2.57 ± 2.1* 0.85 ± 1.2 0.65 ± 1.8**
Urine creatinine [mg/dL] 58.7 ± 1.7 97.1 ± 1.6* 65.3 ± 1.1 59.2 ± 1.4**
Serum urea [mg/dL] 22.9 ± 1.2 92.3 ± 2.1* 26.1 ± 1.7 19.9 ± 3.1**
Urine urea [mg/dL]1 89.6 ± 3.0 109.1 ± 2.0* 95.2 ± 5.0 90.4 ± 5.0**
Urine albumin [mg/dL] 12.5 ± 1.2 29.7 ± 1.5* 16.4 ± 1.2 12.2 ± 1.4**
Serum albumin [mg/dL] 25.5 ± 3.7 13.9 ± 1.9* 26.9 ± 1.2 27.2 ± 1.2**
Creatinine clearance [mL/min] 1.12 ± 0.3 0.56 ± 0.6* 1.09 ± 0.3 1.14 ± 0.3**
Urea clearance [mL/min] 1.42 ± 0.1 0.41 ± 0.4* 1.31 ± 0.1 1.41 ± 0.5**
Values are expressed as means ± SEM of 8–10 rats; *statistically significant at p < 0.05 compared to control; **statistically significant at p < 0.05 compared to STZ-treated
Figure 1. Changes in serum, urine (A), and tissue (B) nitrite concentrations in rats with renal injury after streptozotocin (STZ) and
F. exasperate leaf aqueous extract (FEE) treatments. Results are expressed as means of 8–10 observations.
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treatment resulted in a significant but incomplete
reduction (p < 0.05) in plasma and kidney MDA con-
centrations in diabetic animals (Fig. 3).
Histopathological findings
STZ administration alone caused prominent his-
topathological damage in the kidney compared with
‘control’ rats. Kidney sections from ‘control’ and FEE-
-treated groups of rats showed normal glomeruli and
tubulo-interstitial cells (Fig. 4A, 4D). In contrast, the
kidneys of STZ-treated rats showed marked deleteri-
ous histological changes. The principal findings within
the STZ-treated kidney sections were glomerular and
tubular degenerations, varying from thickening of
periglomerular arteriolar walls and glomerular base-
ment, interstitial inflammation, and tubular cell swell-
ing. STZ exposure also aggravated loss of peritubular
capillaries (Fig. 4B). The FEE-treated group of rats
preserved normal morphology of the kidney and
showed normal architecture of the kidney (Fig. 4C).
DISCUSSION
In this study we examined the effects of F. exas-
perata leaf aqueous extract on the renal function of
STZ-treated rats. The most impressive finding, how-
ever, is related to the histological findings. Indeed,
Figure 2. Changes in (A) renal arterial blood flow and (B) carotid arterial blood flow (n = 6).
Figure 3. Changes in (A) plasma malondialdehyde (MDA) levels and (B) kidney malondialdehyde (MDA) contents in rats with renal injury
after STZ and FEE treatments. P < 0.05 versus ‘control’ and FEE-treated rat groups.
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Figure 4. Photomicrographs of kidney sections stained with haematoxylin-eosin and Masson’s trichrome under light microscope. A. ‘Con-
trol’ rats showing normal rat kidney with normal tubular brush-borders (T) and intact glomeruli (G). No evidence of congestion or inflamma-
tion was observed in the sinusoid; B. Streptozotocin-treated rats showing loss of tubular brush-borders, glomerular hypercellularity (H),
and thickened glomerular basement membrane (g); C. STZ + FEE-treated rats showing attenuated hypercellularity with improved tubular
and glomerular architecture; D. FEE-treated rats showing normal morphology of the kidney. X 200.
one of the major effects of STZ treatment was to
cause a marked worsening of microvascular injury,
as characterised by arteriolar thickening and peritu-
bular capillary loss, which was associated with more
tubular injury and greater interstitial inflammation.
The development of preglomerular microvascular
disease can be a mechanism for renal dysfunction
progression since structural changes alter renal au-
toregulation and favour development of glomeru-
lar hypertension (“the Herrera hypothesis”) [9].
Oxidative stress contributes to renal injury, and
antioxidant supplementation mitigates renal dis-
ease in diabetic and non-diabetic rats [15]. The un-
treated diabetic animals in this study showed sig-
nificant increases in plasma MDA concentration and
marked elevation of kidney MDA content. These
findings suggest ROS-mediated modifications of
lipid, carbohydrate, and protein molecules, denot-
ing the presence of oxidative stress, which is
a known feature of DM [16]. Interestingly, tissue,
serum, and urine nitrite were significantly higher
in the untreated diabetic animals, probably due to
the presence of oxidative stress that could have
raised nitrite abundance via ROS-NO interaction.
This phenomenon can be explained, in part at least,
by the NO production coupled with elevation of
glucose and free fatty acids, rendering them the
dominant targets of ROS in the untreated diabetic
rats. Accordingly, the by-products of ROS interac-
tion with glucose and fatty acids (MDA) were in-
creased in diabetic animals. This phenomenon, to-
gether with attenuation of tubuloglomerular feed-
back response (occasioned by enhanced proximal
tubular sodium reabsorption) [21], contributes to
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FEE administration resulted in marked but incom-
plete reductions in plasma glucose and MDA con-
centrations and tissue MDA contents. This reduc-
tion was coupled with a significant rise in renal urea
and creatinine clearance rate. The latter could be
due to a constellation of up-regulation of NOS iso-
forms, residual oxidative stress associated with good
glycaemic control, and reduction in competition by
glucose and fatty acids for interaction with ROS. In
contrast, a number of other studies have shown up-
regulation of NO production and NOS expression in
diabetic animals and cultured endothelial cells ex-
posed to high glucose concentration [19].
Uncontrolled diabetes of 4 weeks duration in rats
is associated with enhanced lipid, glucose, and pro-
tein oxidation, renal dysfunction, hypertension,
down-regulation of NOS expression, and reduced
nitrotyrosine abundance. It can be concluded that
administration of FEE to STZ-treated diabetic rats
decreased blood glucose levels. This hypoglycaemic
effect of the extract may be due to depression of
key gluconeogenic enzymes, an increase in the le-
vels of glucose transporters, and/or stimulation of
glucose uptake in skeletal muscle cells. Another ob-
vious effect of this plant’s extract is to preserve neph-
ron and renal functions, resulting in a significant
improvement in deranged renal function.
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